Shirley Michelle Shiller, DO
With the advent of next-generation sequencing and novel technologies, the understanding of the molecular alterations in gastrointestinal (GI) cancers has significantly improved.
on Gastrointestinal Cancers, Shiller, a pathologist at Baylor Scott and White Health, discussed progress with precision medicine for patients with gastrointestinal cancers.
OncLive: Please provide an overview of your presentation.
: I discussed the recent guidelines and recommendations, which were a collaborative effort between ASCO and various pathology organizations to ensure that we are streamlining testing.
... to read the full story